[
    {
        "question_id": "1_B_1596",
        "new_question_id": "3454",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1584",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Multiple basal cell carcinomas",
            "Squamous cell carcinoma",
            "Actinic keratoses",
            "Seborrhoeic dermatitis",
            "Seborrhoeic keratoses",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Please look at this man's head:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />These skin lesions have been present for the past year. What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Actinic keratoses</b>. Actinic keratoses (also known as solar keratoses) are pre-malignant lesions that develop on sun-exposed areas of skin, particularly in fair-skinned individuals with a history of chronic sun exposure. The image shows multiple erythematous, scaly patches on the scalp and forehead, which are typical locations for actinic keratoses. These lesions are typically rough to touch, with an adherent scale, and can vary in colour from skin-coloured to reddish-brown. The patient's bald scalp would be particularly vulnerable to UV damage. Actinic keratoses are considered pre-malignant as they have the potential to progress to squamous cell carcinoma in approximately 0.1-10% of cases, although this transformation rate is relatively low.<br /><br /><b>Multiple basal cell carcinomas</b> is incorrect. Basal cell carcinomas (BCCs) typically present as pearly nodules with rolled edges and telangiectasia. They may ulcerate centrally, creating the classic 'rodent ulcer' appearance. While BCCs can occur in multiples, especially in patients with significant sun exposure or genetic predisposition (such as in basal cell naevus syndrome), the flat, scaly appearance of the lesions in the image is not consistent with BCCs, which are typically nodular, cystic, or ulcerated.<br /><br /><b>Squamous cell carcinoma</b> is incorrect. Squamous cell carcinomas (SCCs) typically present as indurated, keratotic nodules or plaques that may ulcerate. They often grow more rapidly than the lesions shown in the image and have a more infiltrative appearance. While SCCs can develop from actinic keratoses, the lesions shown do not have the typical features of invasive SCCs, such as induration, ulceration, or rapid growth.<br /><br /><b>Seborrhoeic dermatitis</b> is incorrect. Seborrhoeic dermatitis presents as erythematous patches with a greasy, yellowish scale, typically affecting the scalp, nasolabial folds, eyebrows, and chest. It is an inflammatory condition that tends to wax and wane, often with periods of flare-ups and remissions. The lesions in the image lack the greasy scale characteristic of seborrhoeic dermatitis and have a more discrete, focal distribution typical of actinic keratoses rather than the more diffuse pattern seen in seborrhoeic dermatitis.<br /><br /><b>Seborrhoeic keratoses</b> is incorrect. Seborrhoeic keratoses are benign epidermal tumours that appear as well-demarcated, 'stuck-on' warty plaques with a velvety or greasy surface. They range in colour from light tan to dark brown or black and have a characteristic 'stuck-on' appearance. The lesions in the image lack the pigmentation and warty texture typical of seborrhoeic keratoses, and instead show the erythematous, scaly appearance characteristic of actinic keratoses.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Please look at this man's head:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd057b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />These skin lesions have been present for the past year. What is the most likely diagnosis?",
        "correct_answer": "3",
        "question_notes": "The correct answer is <b>Actinic keratoses</b>. Actinic keratoses (also known as solar keratoses) are pre-malignant lesions that develop on sun-exposed areas of skin, particularly in fair-skinned individuals with a history of chronic sun exposure. The image shows multiple erythematous, scaly patches on the scalp and forehead, which are typical locations for actinic keratoses. These lesions are typically rough to touch, with an adherent scale, and can vary in colour from skin-coloured to reddish-brown. The patient's bald scalp would be particularly vulnerable to UV damage. Actinic keratoses are considered pre-malignant as they have the potential to progress to squamous cell carcinoma in approximately 0.1-10% of cases, although this transformation rate is relatively low.<br /><br /><b>Multiple basal cell carcinomas</b> is incorrect. Basal cell carcinomas (BCCs) typically present as pearly nodules with rolled edges and telangiectasia. They may ulcerate centrally, creating the classic 'rodent ulcer' appearance. While BCCs can occur in multiples, especially in patients with significant sun exposure or genetic predisposition (such as in basal cell naevus syndrome), the flat, scaly appearance of the lesions in the image is not consistent with BCCs, which are typically nodular, cystic, or ulcerated.<br /><br /><b>Squamous cell carcinoma</b> is incorrect. Squamous cell carcinomas (SCCs) typically present as indurated, keratotic nodules or plaques that may ulcerate. They often grow more rapidly than the lesions shown in the image and have a more infiltrative appearance. While SCCs can develop from actinic keratoses, the lesions shown do not have the typical features of invasive SCCs, such as induration, ulceration, or rapid growth.<br /><br /><b>Seborrhoeic dermatitis</b> is incorrect. Seborrhoeic dermatitis presents as erythematous patches with a greasy, yellowish scale, typically affecting the scalp, nasolabial folds, eyebrows, and chest. It is an inflammatory condition that tends to wax and wane, often with periods of flare-ups and remissions. The lesions in the image lack the greasy scale characteristic of seborrhoeic dermatitis and have a more discrete, focal distribution typical of actinic keratoses rather than the more diffuse pattern seen in seborrhoeic dermatitis.<br /><br /><b>Seborrhoeic keratoses</b> is incorrect. Seborrhoeic keratoses are benign epidermal tumours that appear as well-demarcated, 'stuck-on' warty plaques with a velvety or greasy surface. They range in colour from light tan to dark brown or black and have a characteristic 'stuck-on' appearance. The lesions in the image lack the pigmentation and warty texture typical of seborrhoeic keratoses, and instead show the erythematous, scaly appearance characteristic of actinic keratoses.",
        "answer_order": "3",
        "answer": "3",
        "title": "Actinic keratoses",
        "body": "Actinic, or solar, keratoses (AK) is a common premalignant skin lesion that develops as a consequence of chronic sun exposure<br /><br />Features<br /><ul><li>small, crusty or scaly, lesions</li><li>may be  pink, red, brown or the same colour as the skin</li><li>typically on sun-exposed areas e.g. temples of head</li><li>multiple lesions may be present</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd967b.jpg\" data-fancybox=\"gallery\" data-caption=\"Multiple actinic keratoses - hyperkeratotic papules on a background of sun-damaged skin\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd967.jpg\" alt=\"\" /></a></div></div></div><br />Management options include<br /><ul><li>prevention of further risk: e.g. sun avoidance, sun cream</li><li>fluorouracil cream: typically a 2 to 3 week course. The skin will become red and inflamed - sometimes topical hydrocortisone is given following fluorouracil to help settle the inflammation</li><li>topical diclofenac: may be used for mild AKs. Moderate efficacy but much fewer side-effects</li><li>topical imiquimod: trials have shown good efficacy</li><li>cryotherapy</li><li>curettage and cautery</li></ul>",
        "notes_hash": "7fb6e41b8723e457479e3c12c7055d14",
        "knowledge_graph_node_id_link": 11099,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6703",
        "up_votes": "26",
        "down_votes": "36",
        "column_array": [
            0,
            "412",
            "340",
            "4164",
            "877",
            "910",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>British Association of Dermatologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_919\" data-linkid=\"919\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_919\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_919\" data-linkid=\"919\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_919\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.15107\">2017 Actinic keratoses guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_913\" data-linkid=\"913\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_913\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">22</span><button type=\"button\" style=\"\" id=\"link_dislike_913\" data-linkid=\"913\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_913\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/actinic-keratosis/\">Actinic keratoses</a></td></tr></table><br><br><table style='width:100%'><tr><td>Primary Care Dermatology Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1578\" data-linkid=\"1578\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1578\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">15</span><button type=\"button\" style=\"\" id=\"link_dislike_1578\" data-linkid=\"1578\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1578\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.pcds.org.uk/clinical-guidance/actinic-keratosis-syn.-solar-keratosis\">Actinic keratosis</a></td></tr></table>",
        "media": "",
        "comment_count": 10,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_521",
        "new_question_id": "5303",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "0",
        "notes_id_link": "1_1828",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "<i><i>Helicobacter</i> pylori</i> eradication therapy",
            "Lansoprazole",
            "Amitriptyline",
            "Metoclopramide",
            "Cyclizine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 51-year-old woman who is known to have poorly controlled type 1 diabetes mellitus is reviewed. Her main presenting complaint is bloating and vomiting after eating. She also notes that her blood glucose readings have become more erratic recently. Which one of the following medications is most likely to be beneficial?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The true prevalence of gastroparesis in patients with type 1 diabetes mellitus is not known but most modern studies estimate around 5% are affected. This leads to both upper gastrointestinal symptoms and erratic glucose control due to gastric emptying dysfunction. Metoclopramide is a pro-kinetic drug that can improve gastric emptying.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 51-year-old woman who is known to have poorly controlled type 1 diabetes mellitus is reviewed. Her main presenting complaint is bloating and vomiting after eating. She also notes that her blood glucose readings have become more erratic recently. Which one of the following medications is most likely to be beneficial?",
        "correct_answer": "4",
        "question_notes": "The true prevalence of gastroparesis in patients with type 1 diabetes mellitus is not known but most modern studies estimate around 5% are affected. This leads to both upper gastrointestinal symptoms and erratic glucose control due to gastric emptying dysfunction. Metoclopramide is a pro-kinetic drug that can improve gastric emptying.",
        "answer_order": "4",
        "answer": "4",
        "title": "Diabetic neuropathy",
        "body": "<h5 class='notes-heading'>Peripheral neuropathy</h5><br />Diabetes typically leads to <span class=\"concept\" data-cid=\"4302\">sensory loss</span> and not motor loss. Sensory loss typically results in a '<span class=\"concept\" data-cid=\"11556\">glove and stocking</span>' distribution, with the lower legs affected first due to the length of the sensory neurons supplying this area. Painful diabetic neuropathy is also a common problem in clinical practice.<br /><br />NICE updated it's guidance on the management of neuropathic pain in 2013. Diabetic neuropathy is now managed in the same way as other forms of neuropathic pain:<br /><ul><li>first-line treatment: <span class=\"concept\" data-cid=\"8957\">amitriptyline, duloxetine, gabapentin or pregabalin</span></li><li>if the first-line drug treatment does not work try one of the other 3 drugs</li><li>tramadol may be used as 'rescue therapy' for exacerbations of neuropathic pain</li><li>topical capsaicin may be used for localised neuropathic pain (e.g. post-herpetic neuralgia)</li><li><span class=\"concept\" data-cid=\"3819\">pain management clinics</span> may be useful in patients with resistant problems</li></ul><br /><h5 class='notes-heading'>Gastrointestinal autonomic neuropathy</h5><br />Gastroparesis<br /><ul><li>occurs secondary to autonomic neuropathy</li><li>symptoms include <span class=\"concept\" data-cid=\"3820\">erratic blood glucose control</span>, bloating and <span class=\"concept\" data-cid=\"5415\">vomiting</span></li><li>management options include metoclopramide, domperidone or erythromycin (prokinetic agents)</li></ul><br />Chronic diarrhoea<br /><ul><li>often occurs at <span class=\"concept\" data-cid=\"5414\">night</span></li></ul><br />Gastro-oesophageal reflux disease<br /><ul><li>caused by decreased lower esophageal sphincter (LES) pressure</li></ul>",
        "notes_hash": "6ccce46b0de1baef4bedd9efcdfa982d",
        "knowledge_graph_node_id_link": 11305,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5457",
        "up_votes": "84",
        "down_votes": "31",
        "column_array": [
            0,
            "694",
            "938",
            "209",
            "3225",
            "391",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_755\" data-linkid=\"755\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_755\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_755\" data-linkid=\"755\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_755\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg173/chapter/1-Recommendations\">2013 Neuropathic pain guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_75\" data-linkid=\"75\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_75\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">15</span><button type=\"button\" style=\"\" id=\"link_dislike_75\" data-linkid=\"75\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_75\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations\">2022 Type 2 diabetes guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "21388_B_286",
        "new_question_id": "53849",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "2358",
        "notes_id_link": "1_1087",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Auer rods",
            "Howell-Jolly bodies",
            "Red cell agglutination",
            "Rouleaux formation",
            "Spherocytosis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 67-year-old man presents to the Emergency Department with fatigue and pain deep within his hips. His blood results are as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>108 g/L</td><td>(135 - 180)</td></tr><tr><td>MCV</td><td>95 fl</td><td>(80 - 100)</td></tr><tr><td>Platelets</td><td>106 * 10<sup> 9</sup>/L</td><td>(150 - 400)</td></tr><tr><td>WBC</td><td>8.5 * 10<sup> 9</sup>/L</td><td>(4.0 - 11.0)</td></tr><tr><td>Creatinine</td><td>143 \u00b5mol/L</td><td>(55 - 120)</td></tr><tr><td>Adjusted calcium</td><td>3.02 mmol/L</td><td>(2.2 - 2.7)</td></tr></tbody></table></div><br />Which <b>SINGLE</b> finding on a peripheral blood smear would be diagnostic in this case?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "<b>Rouleaux formation</b> is the correct answer. The patient's clinical presentation, which includes symptoms of anaemia, thrombocytopenia, hypercalcaemia, and renal impairment, aligns with a diagnosis of multiple myeloma. In this disorder, rouleaux formation is commonly observed due to increased serum protein levels (such as immunoglobulins), resulting in the characteristic stacking of red blood cells resembling a stack of coins.<br /><br /><b>Auer rods</b> are incorrect. These needle-shaped inclusions found within the cytoplasm of myeloid blasts indicate acute myeloid leukaemia and have no relevance to multiple myeloma or the clinical and laboratory findings in question.<br /><br /><b>Howell-Jolly bodies</b> are incorrect. These remnants of cell nuclei within red blood cells typically manifest in patients with asplenia or severe haemolytic anaemia and do not match the patient's symptoms or laboratory findings that suggest multiple myeloma.<br /><br /><b>Red cell agglutination</b> is incorrect. This condition occurs predominantly in disorders such as cold agglutinin disease, where there is clumping of red blood cells together; it does not correspond with the characteristics suggestive of multiple myeloma detailed here.<br /><br /><b>Spherocytosis</b> is incorrect. Defined by the presence of spherical red blood cells, spherocytosis usually arises from hereditary spherocytosis or autoimmune haemolytic anaemia and does not coincide with the clinical presentation or laboratory findings indicative of multiple myeloma.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 67-year-old man presents to the Emergency Department with fatigue and pain deep within his hips. His blood results are as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>108 g/L</td><td>(135 - 180)</td></tr><tr><td>MCV</td><td>95 fl</td><td>(80 - 100)</td></tr><tr><td>Platelets</td><td>106 * 10<sup> 9</sup>/L</td><td>(150 - 400)</td></tr><tr><td>WBC</td><td>8.5 * 10<sup> 9</sup>/L</td><td>(4.0 - 11.0)</td></tr><tr><td>Creatinine</td><td>143 \u00b5mol/L</td><td>(55 - 120)</td></tr><tr><td>Adjusted calcium</td><td>3.02 mmol/L</td><td>(2.2 - 2.7)</td></tr></tbody></table></div><br />Which <b>SINGLE</b> finding on a peripheral blood smear would be diagnostic in this case?",
        "correct_answer": "4",
        "question_notes": "<b>Rouleaux formation</b> is the correct answer. The patient's clinical presentation, which includes symptoms of anaemia, thrombocytopenia, hypercalcaemia, and renal impairment, aligns with a diagnosis of multiple myeloma. In this disorder, rouleaux formation is commonly observed due to increased serum protein levels (such as immunoglobulins), resulting in the characteristic stacking of red blood cells resembling a stack of coins.<br /><br /><b>Auer rods</b> are incorrect. These needle-shaped inclusions found within the cytoplasm of myeloid blasts indicate acute myeloid leukaemia and have no relevance to multiple myeloma or the clinical and laboratory findings in question.<br /><br /><b>Howell-Jolly bodies</b> are incorrect. These remnants of cell nuclei within red blood cells typically manifest in patients with asplenia or severe haemolytic anaemia and do not match the patient's symptoms or laboratory findings that suggest multiple myeloma.<br /><br /><b>Red cell agglutination</b> is incorrect. This condition occurs predominantly in disorders such as cold agglutinin disease, where there is clumping of red blood cells together; it does not correspond with the characteristics suggestive of multiple myeloma detailed here.<br /><br /><b>Spherocytosis</b> is incorrect. Defined by the presence of spherical red blood cells, spherocytosis usually arises from hereditary spherocytosis or autoimmune haemolytic anaemia and does not coincide with the clinical presentation or laboratory findings indicative of multiple myeloma.",
        "answer_order": "4",
        "answer": "4",
        "title": "Myeloma: features and investigation",
        "body": "Multiple myeloma (MM) is a haematological malignancy characterised by plasma cell proliferation. It arises due to genetic mutations which occur as B-lymphocytes differentiate into mature plasma cells.<br /><br /><h5 class='notes-heading'>Features</h5><br />The median age at presentation is 70 years old. <br /><br />Use the mnemonic <span class=\"concept\" data-cid=\"2358\"><b>CRABBI</b>:</span><br /><ul><li><u>C</u>alcium<ul><li><span class=\"concept\" data-cid=\"6635\">hypercalcaemia</span></li><li>primary factor: <span class=\"concept\" data-cid=\"9845\">due primarily to increased osteoclastic bone resorption caused by local cytokines (e.g. IL-1, tumour necrosis factor) released by the myeloma cells</span></li><li>much less common contributing factors: impaired renal function, increased renal tubular calcium reabsorption and elevated PTH-rP levels</li><li>this leads to constipation, nausea, anorexia and confusion</li></ul></li><li><u>R</u>enal<ul><li>monoclonal production of immunoglobulins results in <span class=\"concept\" data-cid=\"9538\">light chain deposition within the renal tubules</span></li><li>this causes renal damage which presents as dehydration and increasing thirst</li><li>other causes of renal impairment in myeloma include <span class=\"concept\" data-cid=\"9538\">amyloidosis, nephrocalcinosis, nephrolithiasis</span></li></ul></li><li><u>A</u>naemia<ul><li>bone marrow crowding suppresses erythropoiesis leading to anaemia</li><li>this causes fatigue and pallor</li></ul></li><li><u>B</u>leeding<ul><li>bone marrow crowding also results in thrombocytopenia which puts patients at increased risk of bleeding and bruising</li></ul></li><li><u>B</u>ones<ul><li>bone marrow infiltration by plasma cells and cytokine-mediated osteoclast overactivity creates lytic bone lesions</li><li>this may present as pain (especially in the back) and <span class=\"concept\" data-cid=\"5519\">increases the risk of pathological fractures</span></li></ul></li><li><u>I</u>nfection<ul><li>a reduction in the production of normal immunoglobulins results in increased susceptibility to infection</li></ul></li></ul><br />Other features include<br /><ul><li>amyloidosis e.g. macroglossia</li><li>carpal tunnel syndrome</li><li>neuropathy</li><li>hyperviscosity</li></ul><br /><br /><h5 class='notes-heading'>Investigations</h5><br />Bloods<br /><ul><li>full blood count: anaemia</li><li>peripheral blood film: <span class=\"concept\" data-cid=\"11746\">rouleaux formation</span></li><li>urea and electrolytes: renal failure</li><li>bone profile: hypercalcaemia</li><li>a rise in immunoglobulins may be implied by an elevated (<span class=\"concept\" data-cid=\"169\">total protein - albumin</span>)</li></ul><br />Protein electrophoresis<br /><ul><li>raised concentrations of monoclonal IgA/IgG proteins will be present in the serum</li><li>in the urine, they are known as <span class=\"concept\" data-cid=\"4919\">Bence Jones proteins</span></li></ul><br />Bone marrow aspiration<br /><ul><li>confirms the diagnosis if the number of <span class=\"concept\" data-cid=\"5279\">plasma cells is significantly raised</span></li></ul><br />Imaging<br /><ul><li>historically a skeletal survey has been done to look for bone lesions</li><li>however, <span class=\"concept\" data-cid=\"3666\">whole-body MRI</span> is increasingly used and is now recommended in the 2016 NICE guidelines</li><li>X-rays: 'rain-drop skull' (likened to the pattern rain forms after hitting a surface and splashing, where it leaves a random pattern of dark spots). Note that a very similar, but subtly different finding is found in primary hyperparathyroidism - 'pepperpot skull'</li></ul><br /><br /><h5 class='notes-heading'>Diagnostic criteria</h5><br />The diagnostic criteria for multiple myeloma requires one major and one minor criteria or three minor criteria in an individual who has signs or symptoms of multiple myeloma.<br /><br />Major criteria<br /><ul><li>Plasmacytoma (as demonstrated on evaluation of biopsy specimen)</li><li>30% plasma cells in a bone marrow sample</li><li>Elevated levels of M protein in the blood or urine</li></ul><br />Minor criteria<br /><ul><li>10% to 30% plasma cells in a bone marrow sample.</li><li>Minor elevations in the level of M protein in the blood or urine.</li><li>Osteolytic lesions (as demonstrated on imaging studies).</li><li>Low levels of antibodies (not produced by the cancer cells) in the blood.</li></ul>",
        "notes_hash": "d2883a0c8694b72ab75dc176f6d24fe8",
        "knowledge_graph_node_id_link": 1199,
        "concept": "'CRAB' features of multiple myeloma = hyperCalcaemia, Renal failure, Anaemia (and thrombocytopenia) and Bone fractures/lytic lesions",
        "concept_percentile": "94",
        "concept_colour": "rgb(30,255,0)",
        "number_attempts": "5093",
        "up_votes": "14",
        "down_votes": "15",
        "column_array": [
            0,
            "651",
            "725",
            "181",
            "3225",
            "311",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_157\" data-linkid=\"157\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_157\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">18</span><button type=\"button\" style=\"\" id=\"link_dislike_157\" data-linkid=\"157\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_157\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng35/chapter/Recommendations\">2016 myeloma guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SVlV68XVQLg\" data-description=\"Multiple Myeloma\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"744\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/SVlV68XVQLg/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SVlV68XVQLg\" data-description=\"Multiple Myeloma\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"744\">Multiple Myeloma</a></td></tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1297\" data-mediaid=\"1297\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1297\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1297\" data-mediaid=\"1297\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1297\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jdytgW5wKa4\" data-description=\"What is multiple myeloma?\" data-upvotes=\"7\" data-downvotes=\"2\" data-media=\"381\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/jdytgW5wKa4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jdytgW5wKa4\" data-description=\"What is multiple myeloma?\" data-upvotes=\"7\" data-downvotes=\"2\" data-media=\"381\">What is multiple myeloma?</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_651\" data-mediaid=\"651\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_651\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_651\" data-mediaid=\"651\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_651\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ghvoKhpAc64\" data-description=\"Multiple Myeloma\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1433\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ghvoKhpAc64/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ghvoKhpAc64\" data-description=\"Multiple Myeloma\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1433\">Multiple Myeloma</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2529\" data-mediaid=\"2529\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2529\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2529\" data-mediaid=\"2529\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2529\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_Lm-9vc57AU\" data-description=\"Multiple Myeloma\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1401\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/_Lm-9vc57AU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_Lm-9vc57AU\" data-description=\"Multiple Myeloma\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1401\">Multiple Myeloma</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2466\" data-mediaid=\"2466\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2466\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2466\" data-mediaid=\"2466\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2466\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yi84Tm6gGEc\" data-description=\"Multiple Myeloma Mnemonic...the story of the plasma cell\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"746\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/yi84Tm6gGEc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yi84Tm6gGEc\" data-description=\"Multiple Myeloma Mnemonic...the story of the plasma cell\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"746\">Multiple Myeloma Mnemonic...the story of the plasma cell</a></td></tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1299\" data-mediaid=\"1299\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1299\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1299\" data-mediaid=\"1299\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1299\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eov_LKNsW4k\" data-description=\"Multiple Myeloma - Diagnosis and Treatment\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"745\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/eov_LKNsW4k/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eov_LKNsW4k\" data-description=\"Multiple Myeloma - Diagnosis and Treatment\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"745\">Multiple Myeloma - Diagnosis and Treatment</a></td></tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1298\" data-mediaid=\"1298\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1298\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1298\" data-mediaid=\"1298\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1298\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-TjI1EeXyzA\" data-description=\"Multiple Myeloma\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"801\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/-TjI1EeXyzA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-TjI1EeXyzA\" data-description=\"Multiple Myeloma\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"801\">Multiple Myeloma</a></td></tr><tr><td><span ><small>CRASH! Medical Review - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1392\" data-mediaid=\"1392\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1392\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1392\" data-mediaid=\"1392\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1392\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "2358": {
                "concept_text": "'CRAB' features of multiple myeloma = hyperCalcaemia, Renal failure, Anaemia (and thrombocytopenia) and Bone fractures/lytic lesions",
                "concept_percentile": "94"
            },
            "6635": {
                "concept_text": "Myeloma causes hypercalcaemia",
                "concept_percentile": "32"
            },
            "11746": {
                "concept_text": "Rouleaux formation is seen in myeloma",
                "concept_percentile": "62"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2028",
        "new_question_id": "4472",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "1773",
        "notes_id_link": "1_175",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Hyoscine butylbromide",
            "Omeprazole",
            "Ferrous fumarate",
            "Aspirin",
            "Calcium carbonate",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You are doing a medication review for a 78-year-old patient.  In the past year, they had an admission complicated by <i>C. difficile</i> infection.  Which of the following common medications found on the patient's repeat prescription is associated with increased risk of <i>C. difficile</i> infection and should potentially be discontinued?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "There is evidence that acid suppression medication - proton pump inhibitors more so than H2 antagonists - are associated with increased risk of <i>C. difficile</i> infection (CDI).  Therefore their use should be reviewed in patients with CDI, or who are at high risk of infection, such as those who have had already had episodes of CDI.  Other risk factors for CDI include increasing age, antibiotic use (in particular broad-spectrum antibiotics and multiple antibiotic courses), inflammatory bowel disease, long hospital stays, immunosuppression, and surgery to the GI tract.<br /><br />Sources: <br />Department of Health Updated guidance on the management and treatment of Clostridium difficile infection<br />https://www.gov.uk/government/uploads/system/uploads/attachment</td><td>data/file/321891/Clostridium</td><td>difficile</td><td>management</td><td>and</td><td>treatment.pdf<br /><br />NHS Choices<br />http://www.nhs.uk/Conditions/Clostridium-difficile/Pages/Causes.aspx",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You are doing a medication review for a 78-year-old patient.  In the past year, they had an admission complicated by <i>C. difficile</i> infection.  Which of the following common medications found on the patient's repeat prescription is associated with increased risk of <i>C. difficile</i> infection and should potentially be discontinued?",
        "correct_answer": "2",
        "question_notes": "There is evidence that acid suppression medication - proton pump inhibitors more so than H2 antagonists - are associated with increased risk of <i>C. difficile</i> infection (CDI).  Therefore their use should be reviewed in patients with CDI, or who are at high risk of infection, such as those who have had already had episodes of CDI.  Other risk factors for CDI include increasing age, antibiotic use (in particular broad-spectrum antibiotics and multiple antibiotic courses), inflammatory bowel disease, long hospital stays, immunosuppression, and surgery to the GI tract.<br /><br />Sources: <br />Department of Health Updated guidance on the management and treatment of Clostridium difficile infection<br />https://www.gov.uk/government/uploads/system/uploads/attachment</td><td>data/file/321891/Clostridium</td><td>difficile</td><td>management</td><td>and</td><td>treatment.pdf<br /><br />NHS Choices<br />http://www.nhs.uk/Conditions/Clostridium-difficile/Pages/Causes.aspx",
        "answer_order": "2",
        "answer": "2",
        "title": "<i>Clostridioides difficile</i>",
        "body": "<i>Clostridioides difficile</i> is a <span class=\"concept\" data-cid=\"1867\">Gram positive rod</span> often encountered in hospital practice. It produces an exotoxin which causes intestinal damage leading to a syndrome called pseudomembranous colitis. <i>C. difficile</i> develops when the normal gut flora are suppressed by broad-spectrum antibiotics. <span class=\"concept\" data-cid=\"987\">Clindamycin</span> is historically associated with causing <i>C. difficile</i> but the aetiology has evolved significantly over the past 10 years. Second and third-generation <span class=\"concept\" data-cid=\"431\">cephalosporins</span> are now the leading cause of <i>C. difficile</i>.<br /><br />Other than antibiotics, risk factors include:<br /><ul><li><span class=\"concept\" data-cid=\"1773\">proton pump inhibitors</span></li></ul><br />Pathophysiology<br /><ul><li>anaerobic gram-positive, spore-forming, toxin-producing bacillus </li><li>transmission: via the <span class=\"concept\" data-cid=\"12028\">faecal-oral route by ingestion of spores</span></li><li>releases two exotoxins (toxin A and toxin B) that act on intestinal epithelial cells and inflammatory cells resulting in colitis</li></ul><br />Features<br /><ul><li>diarrhoea</li><li>abdominal pain</li><li>a <b>raised white blood cell count (WCC)</b> is characteristic</li><li>if severe toxic megacolon may develop</li></ul><br />The Public Health England severity scale is often used as this may determine treatment:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Mild</th><th>Moderate</th><th>Severe</th><th>Life-threatening</th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"11061\">Normal WCC</span></td><td><span class=\"concept\" data-cid=\"11061\">\u2191 WCC ( < 15 x 10<sup>9</sup>/L)</span><br />Typically 3-5 loose stools per day</td><td><span class=\"concept\" data-cid=\"11061\">\u2191 WCC ( > 15 x 10<sup>9</sup>/L)</span><br />  or an acutely \u2191 creatinine (> 50% above baseline)<br />  or a temperature > 38.5\u00b0C<br /> or evidence of severe colitis(abdominal or radiological signs)</td><td>Hypotension<br />Partial or complete ileus<br />Toxic megacolon, or CT evidence of severe disease</td></tr></tbody></table></div><br />Diagnosis<br /><ul><li>is made by detecting <i>C. difficile</i> <b>toxin</b> (CDT) in the stool</li><li><i>C. difficile</i> <span class=\"concept\" data-cid=\"9585\"><b>antigen</b> positivity only shows exposure to the bacteria, rather than current infection</span></li></ul><br /><h5 class='notes-heading'>Management</h5><br />Current antibiotic therapy should be reviewed and antibiotics stopped if possible.<br /><br />First episode of <i>C. difficile</i> infection<br /><ul><li><b>first-line therapy is <span class=\"concept\" data-cid=\"1524\">oral vancomycin</span></b> for 10 days</li><li>second-line therapy: <span class=\"concept\" data-cid=\"4516\">oral fidaxomicin</span> </li><li>third-line therapy: <span class=\"concept\" data-cid=\"11463\">oral vancomycin +/- IV metronidazole</span></li></ul><br />Recurrent episode <br /><ul><li>recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode</li><li><span class=\"concept\" data-cid=\"11464\">within 12 weeks of symptom resolution: oral fidaxomicin</span></li><li>after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin</li></ul><br />Life-threatening <i>C. difficile</i> infection<br /><ul><li><span class=\"concept\" data-cid=\"1489\">oral vancomycin AND IV metronidazole</span></li><li>specialist advice - surgery may be considered</li></ul><br />Other therapies<br /><ul><li><span class=\"concept\" data-cid=\"2406\">bezlotoxumab</span> is a monoclonal antibody which targets <i>C. difficile</i> toxin B<ul><li>NICE do not currently support its use to prevent recurrences as it is not cost-effective</li></ul></li><li>faecal microbiota transplant<ul><li>may be considered for patients who've had 2 or more previous episodes</li></ul></li></ul><br /><span class=\"concept\" data-cid=\"12138\">Preventing the spread of <i>C. difficile</i> infection</span><br /><ul><li><span class=\"concept\" data-cid=\"3075\">isolation in side room</span>: the patient should remain isolated until there has been no diarrhoea (types 5-7</li></ul>on the Bristol Stool Chart) for at least 48 hours<br /><ul><li>all staff should wear disposable gloves and an apron during any contact with patients known to have <i>C. difficile</i></li><li>hand washing is also essential - alcohol gel does not kill the spores of <i>C. difficile</i></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb133b.jpg\" data-fancybox=\"gallery\" data-caption=\"Elderly lady with infectious colitis secondary to <i>C. difficile</i>. On the abdominal film note the loss of bowel wall architecture and thumb-printing consistent with colitis. The CT from the same patient is enhanced by oral contrast. There is moderate free fluid in pelvis and peritoneum. The colon is oedematous throughout with enhancing walls, but of normal calibre. The sigmoid colon is smooth and featureless. Small bowel, liver, spleen, kidneys, adrenals and pancreas are normal.\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb133.jpg\" alt=\"\" /></a></div></div></div>",
        "notes_hash": "d9d1ce2c481a73d49cfddd688e80c01b",
        "knowledge_graph_node_id_link": 1152,
        "concept": "PPIs are a risk factor for <i>C. difficile</i> infection ",
        "concept_percentile": "69",
        "concept_colour": "rgb(158,255,0)",
        "number_attempts": "6052",
        "up_votes": "22",
        "down_votes": "4",
        "column_array": [
            0,
            "257",
            "5418",
            "177",
            "70",
            "130",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_87\" data-linkid=\"87\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_87\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_87\" data-linkid=\"87\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_87\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">23</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/advice/esmpb1/chapter/key-points-from-the-evidence\">Clostridium difficile infection: risk with broad-spectrum antibiotics</a></td></tr></table><br><br><table style='width:100%'><tr><td>Canadian Medical Journal</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_854\" data-linkid=\"854\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_854\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_854\" data-linkid=\"854\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_854\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">13</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.cmaj.ca/content/179/8/767/F3.large.jpg\">Relative risk of developing Clostridium difficile</a></td></tr></table><br><br><table style='width:100%'><tr><td>Medcomic</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2062\" data-linkid=\"2062\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2062\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">33</span><button type=\"button\" style=\"\" id=\"link_dislike_2062\" data-linkid=\"2062\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2062\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">13</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.medcomic.com/medcomic/clostridium-difficile-infection\">Clostridium difficile Infection</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2048\" data-linkid=\"2048\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2048\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">40</span><button type=\"button\" style=\"\" id=\"link_dislike_2048\" data-linkid=\"2048\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2048\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng199/chapter/Recommendations\">2021 Clostridioides difficile infection guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Bpe94DaI6Pc\" data-description=\"Understanding Clostridium Difficile Infection\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1501\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Bpe94DaI6Pc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Bpe94DaI6Pc\" data-description=\"Understanding Clostridium Difficile Infection\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1501\">Understanding Clostridium Difficile Infection</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2644\" data-mediaid=\"2644\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2644\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2644\" data-mediaid=\"2644\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2644\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "987": {
                "concept_text": "Clindamycin treatment is associated with a high risk of <i>C. difficile</i>",
                "concept_percentile": "72"
            },
            "1489": {
                "concept_text": "In life-threatening <i>C. difficile</i> infection treatment is with ORAL vancomycin and IV metronidazole",
                "concept_percentile": "95"
            },
            "1524": {
                "concept_text": "Oral vancomycin is the first line antibiotic for use in patients with <i>C. difficile</i> infection",
                "concept_percentile": "51"
            },
            "1773": {
                "concept_text": "PPIs are a risk factor for <i>C. difficile</i> infection ",
                "concept_percentile": "69"
            },
            "4516": {
                "concept_text": "If <i> C. difficile </i> does not respond to first-line vancomycin , oral fidaxomicin should be used next, except in life-threatening infections",
                "concept_percentile": "57"
            },
            "11463": {
                "concept_text": "If a first episode of <i>C. difficile </i> doesn't respond to either vancomycin or fidaxomicin then oral vancomycin +/- IV metronidazole should be tried",
                "concept_percentile": "73"
            },
            "11464": {
                "concept_text": "A recurrent episode of <i>C. difficile</i> within 12 weeks of symptom resolution should be treated with oral fidaxomicin",
                "concept_percentile": "67"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4864_B_46",
        "new_question_id": "15062",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "3529",
        "notes_id_link": "1_1197",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Colchicine",
            "Febuxostat",
            "Allopurinol",
            "No treatment",
            "Probenecid",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 51-year-old man undergoes a routine medical examination as part of a pre-employment check. He reports no symptoms and physical examination is normal. Blood tests are ordered and the results are all within normal range with the exception of the following:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Uric acid</td><td>0.66 mmol/l (0.18-0.48 mmol/l)</td></tr></tbody></table></div><br />The patient has done some reading online and is worried about his risk of gout.<br /><br />Which of the following treatments should be commenced in light of this result?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Gout is associated with high levels of serum uric acid however it is possible to have hyperuricaemia with no noticeable effects. In such cases, NICE recommends against primary prevention of gout as it has been shown to be neither cost-effective nor beneficial to patients. Lifestyle changes (less red meat, alcohol and sugar) can reduce uric acid levels without drug treatment and so can be advised.<br /><br />The other possible answers all play a role in the treatment of gout, however, would not be indicated in the absence of symptoms.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 51-year-old man undergoes a routine medical examination as part of a pre-employment check. He reports no symptoms and physical examination is normal. Blood tests are ordered and the results are all within normal range with the exception of the following:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Uric acid</td><td>0.66 mmol/l (0.18-0.48 mmol/l)</td></tr></tbody></table></div><br />The patient has done some reading online and is worried about his risk of gout.<br /><br />Which of the following treatments should be commenced in light of this result?",
        "correct_answer": "4",
        "question_notes": "Gout is associated with high levels of serum uric acid however it is possible to have hyperuricaemia with no noticeable effects. In such cases, NICE recommends against primary prevention of gout as it has been shown to be neither cost-effective nor beneficial to patients. Lifestyle changes (less red meat, alcohol and sugar) can reduce uric acid levels without drug treatment and so can be advised.<br /><br />The other possible answers all play a role in the treatment of gout, however, would not be indicated in the absence of symptoms.",
        "answer_order": "4",
        "answer": "4",
        "title": "Hyperuricaemia",
        "body": "Increased levels of uric acid may be seen secondary to either increased cell turnover or reduced renal excretion of uric acid. Hyperuricaemia may be found in asymptomatic patients who have not experienced attacks of gout<br /><br />Hyperuricaemia may be associated with hyperlipidaemia and hypertension. It may also be seen in conjunction with the metabolic syndrome<br /><br />Increased synthesis<br /><ul><li>Lesch-Nyhan disease</li><li>myeloproliferative disorders</li><li>diet rich in purines</li><li>exercise</li><li>psoriasis</li><li>cytotoxics</li></ul>   <br />Decreased excretion<br /><ul><li>drugs: low-dose aspirin, diuretics, pyrazinamide</li><li>pre-eclampsia</li><li>alcohol</li><li>renal failure</li><li>lead</li></ul>",
        "notes_hash": "b23edacb5bc9aad298c6a981b226588b",
        "knowledge_graph_node_id_link": 0,
        "concept": "Treatment of asymptomatic hyperuricaemia in an attempt to prevent gout is not recommended by NICE",
        "concept_percentile": "81",
        "concept_colour": "rgb(96,255,0)",
        "number_attempts": "5422",
        "up_votes": "42",
        "down_votes": "20",
        "column_array": [
            0,
            "331",
            "84",
            "1660",
            "3329",
            "18",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DaYSpcMmZbU\" data-description=\"Lesch-Nyhan syndrome\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"603\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/DaYSpcMmZbU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DaYSpcMmZbU\" data-description=\"Lesch-Nyhan syndrome\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"603\">Lesch-Nyhan syndrome</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1023\" data-mediaid=\"1023\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1023\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1023\" data-mediaid=\"1023\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1023\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_347",
        "new_question_id": "9565",
        "question_type": "0",
        "category": "8",
        "concept_id_link": "6220",
        "notes_id_link": "1_621",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Doxorubicin",
            "Bleomycin",
            "Cisplatin",
            "Cyclophosphamide",
            "Vincristine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Which of the following cytotoxic agents is most associated with lung fibrosis?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "Bleomycin is a cytotoxic antibiotic used to treat metastatic germ cell cancer, squamous cell carcinoma and in some regimes non-Hodgkin's lymphoma. Lung fibrosis is the major adverse effect and is dose-related",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Which of the following cytotoxic agents is most associated with lung fibrosis?",
        "correct_answer": "2",
        "question_notes": "Bleomycin is a cytotoxic antibiotic used to treat metastatic germ cell cancer, squamous cell carcinoma and in some regimes non-Hodgkin's lymphoma. Lung fibrosis is the major adverse effect and is dose-related",
        "answer_order": "2",
        "answer": "2",
        "title": "Cytotoxic agents",
        "body": "The tables below summarises the mechanism of action and major adverse effects of commonly used cytotoxic agents.<br /><br /><h5 class='notes-heading'>Alkylating agents</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Cyclophosphamide</td><td><span class=\"concept\" data-cid=\"6235\">Alkylating agent - causes cross-linking in DNA</span></td><td><span class=\"concept\" data-cid=\"6225\">Haemorrhagic cystitis</span>, <span class=\"concept\" data-cid=\"6226\">myelosuppression</span>, <span class=\"concept\" data-cid=\"2707\">transitional cell carcinoma</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Cytotoxic antibiotics</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Bleomycin</td><td><span class=\"concept\" data-cid=\"6232\">Degrades preformed DNA</span></td><td><span class=\"concept\" data-cid=\"6220\">Lung fibrosis</span></td></tr><tr><td>Anthracyclines (e.g doxorubicin)</td><td><span class=\"concept\" data-cid=\"6233\">Stabilizes DNA-topoisomerase II complex   inhibits DNA & RNA synthesis</span></td><td><span class=\"concept\" data-cid=\"6221\">Cardiomyopathy</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Antimetabolites</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Methotrexate</td><td><span class=\"concept\" data-cid=\"6234\">Inhibits dihydrofolate reductase and thymidylate synthesis</span></td><td><span class=\"concept\" data-cid=\"6222\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6223\">mucositis</span>, <span class=\"concept\" data-cid=\"6224\">liver fibrosis</span>, <span class=\"concept\" data-cid=\"4323\">lung fibrosis</span></td></tr><tr><td>Fluorouracil (5-FU)</td><td><span class=\"concept\" data-cid=\"6237\">Pyrimidine analogue inducing cell cycle arrest and apoptosis by blocking thymidylate synthase (works during S phase)</span></td><td><span class=\"concept\" data-cid=\"6227\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6228\">mucositis</span>, <span class=\"concept\" data-cid=\"6229\">dermatitis</span></td></tr><tr><td>6-mercaptopurine</td><td><span class=\"concept\" data-cid=\"6242\">Purine analogue that is activated by HGPRTase, decreasing purine synthesis</span></td><td>Myelosuppression</td></tr><tr><td>Cytarabine</td><td><span class=\"concept\" data-cid=\"6245\">Pyrimidine antagonist. Interferes with DNA synthesis specifically at the S-phase of the cell cycle and inhibits DNA polymerase</span></td><td><span class=\"concept\" data-cid=\"6246\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6247\">ataxia</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Acts on microtubules</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid4\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Vincristine, vinblastine</td><td><span class=\"concept\" data-cid=\"6230\">Inhibits formation of microtubules</span></td><td>Vincristine: <span class=\"concept\" data-cid=\"785\">Peripheral neuropathy (reversible)</span> , <span class=\"concept\" data-cid=\"6239\">paralytic ileus</span><br />Vinblastine: <span class=\"concept\" data-cid=\"6240\">myelosuppression</span></td></tr><tr><td>Docetaxel</td><td><span class=\"concept\" data-cid=\"787\">Prevents microtubule depolymerisation & disassembly, decreasing free tubulin</span></td><td>Neutropaenia</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Topoisomerase Inhibitors</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid5\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Irinotecan</td><td><span class=\"concept\" data-cid=\"9280\">Inhibits topoisomerase I which prevents relaxation of supercoiled DNA</span></td><td>Myelosuppression</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Other cytotoxic drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid6\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Cisplatin</td><td><span class=\"concept\" data-cid=\"6231\">Causes cross-linking in DNA</span></td><td><span class=\"concept\" data-cid=\"12272\">Nephrotoxicity (the primary dose-limiting side effect)</span>, <span class=\"concept\" data-cid=\"6219\">Ototoxicity</span>, <span class=\"concept\" data-cid=\"788\">peripheral neuropathy</span>, <span class=\"concept\" data-cid=\"786\">hypomagnesaemia</span></td></tr><tr><td>Hydroxyurea (hydroxycarbamide)</td><td><span class=\"concept\" data-cid=\"6243\">Inhibits ribonucleotide reductase, decreasing DNA synthesis</span></td><td><span class=\"concept\" data-cid=\"6244\">Myelosuppression</span></td></tr></tbody></table></div>",
        "notes_hash": "8b3d85754acea1f462557a8a6ac97eb4",
        "knowledge_graph_node_id_link": 0,
        "concept": "Bleomycin may cause pulmonary fibrosis",
        "concept_percentile": "20",
        "concept_colour": "rgb(255,102,0)",
        "number_attempts": "5868",
        "up_votes": "36",
        "down_votes": "15",
        "column_array": [
            0,
            "410",
            "3951",
            "588",
            "607",
            "312",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Toxicity Bear's very own website</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1494\" data-linkid=\"1494\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1494\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">417</span><button type=\"button\" style=\"\" id=\"link_dislike_1494\" data-linkid=\"1494\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1494\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://pbs.twimg.com/media/BKVx5a3CUAAa1z2.png\">Toxicity Bear</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/t7QDJOXeux4\" data-description=\"Pharmacology - Chemotherapy agents\" data-upvotes=\"13\" data-downvotes=\"2\" data-media=\"834\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/t7QDJOXeux4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/t7QDJOXeux4\" data-description=\"Pharmacology - Chemotherapy agents\" data-upvotes=\"13\" data-downvotes=\"2\" data-media=\"834\">Pharmacology - Chemotherapy agents</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1461\" data-mediaid=\"1461\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1461\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"media_dislike_1461\" data-mediaid=\"1461\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1461\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VD8h0XsEFho\" data-description=\"Cancer Pharmacology\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"1025\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/VD8h0XsEFho/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VD8h0XsEFho\" data-description=\"Cancer Pharmacology\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"1025\">Cancer Pharmacology</a></td></tr><tr><td><span ><small>DirtyUSMLE - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1802\" data-mediaid=\"1802\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1802\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1802\" data-mediaid=\"1802\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1802\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gYIAFXlfEw8\" data-description=\"Microtubule inhibitors\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1359\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/gYIAFXlfEw8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gYIAFXlfEw8\" data-description=\"Microtubule inhibitors\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1359\">Microtubule inhibitors</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2389\" data-mediaid=\"2389\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2389\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2389\" data-mediaid=\"2389\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2389\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "785": {
                "concept_text": "Vincristine - peripheral neuropathy",
                "concept_percentile": "28"
            },
            "786": {
                "concept_text": "Cisplatin is associated with hypomagnesaemia",
                "concept_percentile": "1"
            },
            "6219": {
                "concept_text": "Cisplatin may cause ototoxicity",
                "concept_percentile": "10"
            },
            "6220": {
                "concept_text": "Bleomycin may cause pulmonary fibrosis",
                "concept_percentile": "20"
            },
            "6221": {
                "concept_text": "Anthracyclines (e.g. doxorubicin) may cause cardiomyopathy",
                "concept_percentile": "15"
            },
            "6222": {
                "concept_text": "Methotrexate may cause myelosuppression/agranulocytosis",
                "concept_percentile": "100"
            },
            "6223": {
                "concept_text": "Methotrexate may cause mucositis",
                "concept_percentile": "99"
            },
            "6224": {
                "concept_text": "Methotrexate may cause liver fibrosis",
                "concept_percentile": "100"
            },
            "6225": {
                "concept_text": "Cyclophosphamide may cause haemorrhagic cystitis",
                "concept_percentile": "4"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_9460",
        "new_question_id": "2980",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1490",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "On covering the left eye the right eye moves medially to take up fixation",
            "The cover test could not be used to identify this type of defect",
            "On covering the left eye the right eye moves laterally to take up fixation",
            "On covering the right eye the left eye moves laterally to take up fixation",
            "On covering the right eye the left eye moves medially to take up fixation",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A mother brings her son in to surgery as she suspects he has a squint. She thinks his right eye is 'turned inwards'. You perform a cover test to gather further information. Which one of the following findings would be consistent with a right esotropia?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "Squints may be classified as to where the eye deviates toward<br /><ul><li>the nose: esotropia</li><li>temporally: exotropia</li><li>superiorly: hypertropia</li><li>inferiorly: hypotropia</li></ul><br />On covering the left eye in this example the right eye moves laterally from the nasal (esotropic) position to take up fixation.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A mother brings her son in to surgery as she suspects he has a squint. She thinks his right eye is 'turned inwards'. You perform a cover test to gather further information. Which one of the following findings would be consistent with a right esotropia?",
        "correct_answer": "3",
        "question_notes": "Squints may be classified as to where the eye deviates toward<br /><ul><li>the nose: esotropia</li><li>temporally: exotropia</li><li>superiorly: hypertropia</li><li>inferiorly: hypotropia</li></ul><br />On covering the left eye in this example the right eye moves laterally from the nasal (esotropic) position to take up fixation.",
        "answer_order": "3",
        "answer": "3",
        "title": "Squint",
        "body": "Squint (strabismus) is characterised by misalignment of the visual axes. Squints may be divided into concomitant (common) and paralytic (rare). It is important to detect as uncorrected may lead to <span class=\"concept\" data-cid=\"11675\">amblyopia</span> (the brain fails to fully process inputs from one eye and over time favours the other eye).<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Concomitant</b></th><th><b>Paralytic</b></th></tr></thead><tbody><tr><td>Due to imbalance in extraocular muscles<br />Convergent is more common than divergent</td><td>Due to paralysis of extraocular muscles</td></tr></tbody></table></div><br />Detection of a squint may be made by the corneal light reflection test - holding a light source 30cm from the child's face to see if the light reflects symmetrically on the pupils<br /><br />The cover test is used to identify the nature of the squint<br /><ul><li>ask the child to focus on an object</li><li>cover one eye</li><li>observe movement of uncovered eye</li><li>cover other eye and repeat test </li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"313\">referral to secondary care</span><ul><li>eye patches may help prevent amblyopia</li></ul></li></ul>",
        "notes_hash": "5cd17b915776b0ceba3f1f583581d06a",
        "knowledge_graph_node_id_link": 11236,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6576",
        "up_votes": "39",
        "down_votes": "28",
        "column_array": [
            0,
            "1791",
            "223",
            "3758",
            "461",
            "343",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Ophthalmologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2084\" data-linkid=\"2084\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2084\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_2084\" data-linkid=\"2084\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2084\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcophth.ac.uk/wp-content/uploads/2021/08/2012-SCI-250-Guidelines-for-Management-of-Strabismus-in-Childhood-2012.pdf\">2012 Guidelines for the Management of Strabismus in Childhood </a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Wf8DGL7WE8U\" data-description=\"Cover Test\" data-upvotes=\"49\" data-downvotes=\"1\" data-media=\"223\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Wf8DGL7WE8U/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Wf8DGL7WE8U\" data-description=\"Cover Test\" data-upvotes=\"49\" data-downvotes=\"1\" data-media=\"223\">Cover Test</a></td></tr><tr><td><span ><small>U-M Kellogg Eye Center - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_367\" data-mediaid=\"367\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_367\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">49</span><button type=\"button\" style=\"\" id=\"media_dislike_367\" data-mediaid=\"367\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_367\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ortazh01baM\" data-description=\"Corneal reflections\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"1070\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ortazh01baM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ortazh01baM\" data-description=\"Corneal reflections\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"1070\">Corneal reflections</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1864\" data-mediaid=\"1864\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1864\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1864\" data-mediaid=\"1864\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1864\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "313": {
                "concept_text": "Refer children with a squint to ophthalmology",
                "concept_percentile": "95"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_114",
        "new_question_id": "5502",
        "question_type": "1",
        "category": "5",
        "concept_id_link": "0",
        "notes_id_link": "1_1873",
        "theme": "Respiratory pathogens",
        "instruction": "For each of the following scenarios please select the most likely causative respiratory pathogen:",
        "options": [
            "",
            "Adenovirus",
            "Parainfluenza virus",
            "<i>Mycobacterium tuberculosis</i>",
            "Pneumocystis jiroveci",
            "Respiratory syncytial virus",
            "<i>Mycoplasma pneumoniae</i>",
            "Rhinovirus",
            "<i>Legionella pneumophilia</i>",
            "<i><i>Streptococcus</i> pneumoniae</i>",
            "<i><i>Staphylococcus</i> aureus</i>"
        ],
        "num_of_options": 10,
        "questions": [
            "A 40-year-old man develops pneumonia following an episode of influenza",
            "M 30-kqmd-axp iaymz ue mpyuffqp iuft bzqgyazum fa taebufmx. Etq tme m rqhqd mzp m pdk oagst. Az qjmyuzmfuaz qdkftqym ygxfuradyq ue zafqp mzp nxaape etai etq tme m zadyaokfuo mzmqyum.",
            "Ftqdq ue mz agfndqmw ar dqebudmfadk fdmof uzrqofuaze az m odgueq etub. Nxaape rday azq bmeeqzsqd etai pqdmzsqp xuhqd rgzofuaz fqefe mzp tkbazmfdmqyum."
        ],
        "answers": [
            "10",
            "6",
            "8"
        ],
        "notes": [
            "",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 40-year-old man develops pneumonia following an episode of influenza",
        "correct_answer": "10",
        "question_notes": "",
        "answer_order": "10",
        "answer": "10",
        "title": "Respiratory pathogens",
        "body": "The table below lists the more common respiratory pathogens:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Pathogen</b></th><th><b>Associated condition</b></th></tr></thead><tbody><tr><td>Respiratory syncytial virus</td><td>Bronchiolitis</td></tr><tr><td>Parainfluenza virus</td><td>Croup</td></tr><tr><td>Rhinovirus</td><td><span class=\"concept\" data-cid=\"8738\">Common cold</span></td></tr><tr><td>Influenza virus</td><td>Flu</td></tr><tr><td><i>Streptococcus pneumoniae</i></td><td>The most common cause of <span class=\"concept\" data-cid=\"8739\">community-acquired pneumonia</span></td></tr><tr><td><i>Haemophilus influenzae</i></td><td>Community-acquired pneumonia<br />Most common cause of <span class=\"concept\" data-cid=\"8741\">bronchiectasis exacerbations</span><br /><span class=\"concept\" data-cid=\"8742\">Acute epiglottitis</span></td></tr><tr><td><i>Staphylococcus aureus</i></td><td>Pneumonia, particularly <span class=\"concept\" data-cid=\"8740\">following influenza</span></td></tr><tr><td><i>Mycoplasma pneumoniae</i></td><td>Atypical pneumonia<br /><br />Flu-like symptoms classically precede a dry cough. Complications include haemolytic anaemia and erythema multiforme</td></tr><tr><td><i>Legionella pneumophilia</i></td><td>Atypical pneumonia<br /><br />Classically spread by air-conditioning systems, causes dry cough. Lymphopenia, deranged liver function tests and hyponatraemia may be seen</td></tr><tr><td>Pneumocystis jiroveci</td><td>Common cause of pneumonia in HIV patients. Typically patients have few chest signs and develop exertional dyspnoea</td></tr><tr><td><i>Mycobacterium tuberculosis</i></td><td>Causes tuberculosis. A wide range of presentations from asymptomatic to disseminated disease are possible. Cough, night sweats and weight loss may be seen</td></tr></tbody></table></div>",
        "notes_hash": "49b542ee852fea31ca550b67167448bd",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5110",
        "up_votes": "44",
        "down_votes": "22",
        "column_array": [
            0,
            "3100",
            "4116",
            "4548",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 5,
        "concepts_for_notes": {
            "8738": {
                "concept_text": "Common cold - rhinovirus",
                "concept_percentile": "43"
            },
            "8739": {
                "concept_text": "Community-acquired pneumonia - <i>Streptococcus pneumoniae</i>",
                "concept_percentile": "53"
            },
            "8740": {
                "concept_text": "Pneumonia following influenza - <i>Staphylococcus aureus</i>",
                "concept_percentile": "24"
            },
            "8741": {
                "concept_text": "Exacerbation of bronchiectasis - <i>Haemophilus influenzae</i>",
                "concept_percentile": "70"
            },
            "8742": {
                "concept_text": "Acute epiglottitis - <i>Haemophilus influenzae</i>",
                "concept_percentile": "44"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4598_B_11",
        "new_question_id": "19911",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "9732",
        "notes_id_link": "1_1180",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Warfarin or a direct thrombin or factor Xa inhibitor",
            "Aspirin",
            "Clopidogrel",
            "Dipyridamole",
            "Enoxaparin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 76-year-old lady is brought in by ambulance to the emergency department. She presents with a right-sided limb weakness, a facial droop and slurred speech. A CT head was arranged which ruled out a haemorrhage, but did report a left-sided infarct. Her admission ECG shows that she has new atrial fibrillation (AF). She is treated with aspirin 300mg for the acute stroke and doing well on the ward. <br /><br />Two weeks later she is reviewed. What medication should the patient be started on to reduce the risk of further stroke?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "Aspirin/dipyridamole should only be given if needed for the treatment of other comorbidities. None are mentioned in the above scenario.<br /><br />Clopidogrel would be started in TIA (transient ischaemic attack) patients, in the absence of AF (atrial fibrillation). This patient had a stroke, and if she did not have AF would be started on long term clopidogrel. <br /><br />Enoxaparin would not be prescribed long term but can be used for bridging whilst a patient is started on warfarin, until their INR is within range.<br /><br />Warfarin or a new oral anticoagulant (NOAC) should be started for a patient with AF who has had a new TIA or stroke. This is because their risk of having a further cerebrovascular event is increased (2 points on the CHA\u201a\u201aDS\u201a\u201a-VASc score).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 76-year-old lady is brought in by ambulance to the emergency department. She presents with a right-sided limb weakness, a facial droop and slurred speech. A CT head was arranged which ruled out a haemorrhage, but did report a left-sided infarct. Her admission ECG shows that she has new atrial fibrillation (AF). She is treated with aspirin 300mg for the acute stroke and doing well on the ward. <br /><br />Two weeks later she is reviewed. What medication should the patient be started on to reduce the risk of further stroke?",
        "correct_answer": "1",
        "question_notes": "Aspirin/dipyridamole should only be given if needed for the treatment of other comorbidities. None are mentioned in the above scenario.<br /><br />Clopidogrel would be started in TIA (transient ischaemic attack) patients, in the absence of AF (atrial fibrillation). This patient had a stroke, and if she did not have AF would be started on long term clopidogrel. <br /><br />Enoxaparin would not be prescribed long term but can be used for bridging whilst a patient is started on warfarin, until their INR is within range.<br /><br />Warfarin or a new oral anticoagulant (NOAC) should be started for a patient with AF who has had a new TIA or stroke. This is because their risk of having a further cerebrovascular event is increased (2 points on the CHA\u201a\u201aDS\u201a\u201a-VASc score).",
        "answer_order": "1",
        "answer": "1",
        "title": "Atrial fibrillation: post-stroke",
        "body": "Atrial fibrillation is one of the key risk factors for ischaemic stroke. It is therefore very important to recognise and treat atrial fibrillation if it's identified in a patient following a stroke or transient ischaemic attack (TIA).<br /><br />Management<br /><ul><li>following a stroke or TIA it is obviously important to exclude a haemorrhage before starting any anticoagulation or antiplatelet therapy</li><li>for longer-term stroke prevention, NICE recommend <span class=\"concept\" data-cid=\"9732\">warfarin or a direct thrombin or factor Xa inhibitor</span></li><li>the timing of when to start depends on whether it is a TIA or stroke<ul><li><span class=\"concept\" data-cid=\"11842\">following a TIA, anticoagulation for AF should start immediately</span> once imaging has excluded haemorrhage</li><li>in acute stroke patients, in the absence of haemorrhage, <span class=\"concept\" data-cid=\"9733\">anticoagulation therapy should be commenced after 2 weeks</span>. Antiplatelet therapy should be given in the intervening period. If imaging shows a very large cerebral infarction then the initiation of anticoagulation should be delayed</li></ul></li></ul>",
        "notes_hash": "fba71f642a42c2d4987e56e366b61c35",
        "knowledge_graph_node_id_link": 1162,
        "concept": "If a patient with AF has a stroke or TIA, the anticoagulant of choice should be warfarin or a direct thrombin or factor Xa inhibitor",
        "concept_percentile": "75",
        "concept_colour": "rgb(127,255,0)",
        "number_attempts": "9392",
        "up_votes": "53",
        "down_votes": "44",
        "column_array": [
            0,
            "4191",
            "276",
            "4190",
            "111",
            "624",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2041\" data-linkid=\"2041\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2041\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_2041\" data-linkid=\"2041\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2041\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">28</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng196/chapter/Recommendations\">2021 Atrial fibrillation guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 6,
        "concepts_for_notes": {
            "9732": {
                "concept_text": "If a patient with AF has a stroke or TIA, the anticoagulant of choice should be warfarin or a direct thrombin or factor Xa inhibitor",
                "concept_percentile": "75"
            },
            "9733": {
                "concept_text": "A patient with AF + an acute stroke (not haemorrhagic) should have anticoagulation therapy started two weeks after the event",
                "concept_percentile": "97"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1088_B_3001",
        "new_question_id": "10196",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "0",
        "notes_id_link": "1_774",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Anti-CCP (cyclic citrullinated peptide) antibody",
            "Anti-Jo1 antibody",
            "ANCA (anti-neutrophil cytoplasmic antibody)",
            "Anti-dsDNA antibody",
            "Anti-Ro / Anti-La antibodies",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 60-year-old man presents with weakness and a skin rash on his upper eyelids.  He also complains of a cough which has been present for 3 months.  He has a 60 pack-year smoking history.  On examination he is noted to have symmetrical proximal muscle weakness. <br /><br />What is the most appropriate test from the options below?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Anti-Jo1 antibody</b>. This patient's presentation is highly suggestive of dermatomyositis, specifically antisynthetase syndrome. The key features include proximal muscle weakness, characteristic heliotrope rash on the eyelids, and interstitial lung disease (suggested by chronic cough). Anti-Jo1 antibodies are found in approximately 20-30% of patients with inflammatory myositis and are particularly associated with antisynthetase syndrome. The presence of these antibodies is associated with interstitial lung disease, making this test particularly relevant given the patient's respiratory symptoms.<br /><br /><b>Anti-CCP antibody</b> testing would not be appropriate here as this is primarily used in the diagnosis of rheumatoid arthritis. While RA can cause muscle weakness, it typically presents with symmetric polyarthritis affecting small joints, which is not described in this case.<br /><br /><b>ANCA</b> testing would be more appropriate for investigating vasculitides such as granulomatosis with polyangiitis or microscopic polyangiitis. These conditions typically present with different clinical features including renal involvement and upper respiratory tract symptoms, which are not present in this case.<br /><br /><b>Anti-dsDNA antibody</b> testing is primarily used in the diagnosis and monitoring of systemic lupus erythematosus (SLE). While SLE can cause muscle weakness, the characteristic heliotrope rash and the pattern of proximal muscle weakness are more consistent with dermatomyositis than SLE.<br /><br /><b>Anti-Ro/Anti-La antibodies</b> are primarily associated with Sj\u00f6gren's syndrome and SLE. While these conditions can have muscle involvement, they typically present with different clinical features such as dry eyes and dry mouth in Sj\u00f6gren's syndrome. The clinical picture described is not typical for conditions where these antibodies would be most relevant.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 60-year-old man presents with weakness and a skin rash on his upper eyelids.  He also complains of a cough which has been present for 3 months.  He has a 60 pack-year smoking history.  On examination he is noted to have symmetrical proximal muscle weakness. <br /><br />What is the most appropriate test from the options below?",
        "correct_answer": "2",
        "question_notes": "The correct answer is <b>Anti-Jo1 antibody</b>. This patient's presentation is highly suggestive of dermatomyositis, specifically antisynthetase syndrome. The key features include proximal muscle weakness, characteristic heliotrope rash on the eyelids, and interstitial lung disease (suggested by chronic cough). Anti-Jo1 antibodies are found in approximately 20-30% of patients with inflammatory myositis and are particularly associated with antisynthetase syndrome. The presence of these antibodies is associated with interstitial lung disease, making this test particularly relevant given the patient's respiratory symptoms.<br /><br /><b>Anti-CCP antibody</b> testing would not be appropriate here as this is primarily used in the diagnosis of rheumatoid arthritis. While RA can cause muscle weakness, it typically presents with symmetric polyarthritis affecting small joints, which is not described in this case.<br /><br /><b>ANCA</b> testing would be more appropriate for investigating vasculitides such as granulomatosis with polyangiitis or microscopic polyangiitis. These conditions typically present with different clinical features including renal involvement and upper respiratory tract symptoms, which are not present in this case.<br /><br /><b>Anti-dsDNA antibody</b> testing is primarily used in the diagnosis and monitoring of systemic lupus erythematosus (SLE). While SLE can cause muscle weakness, the characteristic heliotrope rash and the pattern of proximal muscle weakness are more consistent with dermatomyositis than SLE.<br /><br /><b>Anti-Ro/Anti-La antibodies</b> are primarily associated with Sj\u00f6gren's syndrome and SLE. While these conditions can have muscle involvement, they typically present with different clinical features such as dry eyes and dry mouth in Sj\u00f6gren's syndrome. The clinical picture described is not typical for conditions where these antibodies would be most relevant.",
        "answer_order": "2",
        "answer": "2",
        "title": "Dermatomyositis",
        "body": "Overview<br /><ul><li>an inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions</li><li>may be idiopathic or associated with connective tissue disorders or <span class=\"concept\" data-cid=\"2709\">underlying malignancy</span> (typically ovarian, breast and lung cancer, found in 20-25% - more if patient older). <span class=\"concept\" data-cid=\"4160\">Screening for an underlying malignancy</span> is usually performed following a diagnosis of dermatomyositis</li><li>polymyositis is a variant of the disease where skin manifestations are not prominent</li></ul><br />Skin features<br /><ul><li>photosensitive</li><li>macular rash over back and shoulder</li><li>heliotrope rash in the periorbital region</li><li><span class=\"concept\" data-cid=\"2665\">Gottron's papules - roughened red papules over extensor surfaces of fingers</span></li><li> 'mechanic's hands': extremely dry and scaly hands with linear 'cracks' on the palmar and lateral aspects of the fingers</li><li>nail fold capillary dilatation</li></ul><br />Other features<br /><ul><li>proximal muscle weakness +/- tenderness</li><li>Raynaud's</li><li>respiratory muscle weakness</li><li>interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia</li><li>dysphagia, dysphonia</li></ul><br />Investigations<br /><ul><li>the majority of patients (around 80%) are ANA positive</li><li>around 30% of patients have antibodies to aminoacyl-tRNA synthetases (anti-synthetase antibodies), including:<ul><li><span class=\"concept\" data-cid=\"9286\">antibodies against histidine-tRNA ligase (also called Jo-1)</span></li><li>antibodies to signal recognition particle (SRP)</li><li>anti-Mi-2 antibodies</li></ul></li></ul>",
        "notes_hash": "b4954774d646eebc091d256ac2500f83",
        "knowledge_graph_node_id_link": 1416,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4234",
        "up_votes": "3",
        "down_votes": "2",
        "column_array": [
            0,
            "279",
            "2386",
            "492",
            "488",
            "589",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2030\" data-linkid=\"2030\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2030\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_2030\" data-linkid=\"2030\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2030\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://dermnetnz.org/topics/adult-onset-dermatomyositis/\">Dermatomyositis</a></td></tr></table><br><br><table style='width:100%'><tr><td>Primary Care Dermatology Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2031\" data-linkid=\"2031\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2031\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_2031\" data-linkid=\"2031\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2031\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.pcds.org.uk/clinical-guidance/dermatomyositis\">Dermatomyositis (including polymyositis)</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/cZbj0EhOFQI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\">Polymyositis and Dermatomyositis in 3 Minutes</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2457\" data-mediaid=\"2457\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2457\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">39</span><button type=\"button\" style=\"\" id=\"media_dislike_2457\" data-mediaid=\"2457\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2457\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/FGAEw97Etb4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\">Understanding Myositis (Polymyositis and Dermatomyositis)</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2637\" data-mediaid=\"2637\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2637\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_2637\" data-mediaid=\"2637\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2637\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ekRZkjTlgro/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\">Dermatomyositis Overview</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2708\" data-mediaid=\"2708\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2708\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2708\" data-mediaid=\"2708\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2708\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "2665": {
                "concept_text": "Gottron's papules, roughened red papules over the knuckles mainly, are seen in dermatomyositis \r\n",
                "concept_percentile": "73"
            },
            "9286": {
                "concept_text": "Dermatomyositis is associated with the anti-Jo-1 antibody",
                "concept_percentile": "47"
            }
        },
        "optimisation_reason": ""
    }
]